You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 13, 2024

Details for New Drug Application (NDA): 017106

✉ Email this page to a colleague

« Back to Dashboard

NDA 017106 describes ATROPEN, which is a drug marketed by MMT and is included in one NDA. It is available from one supplier. Additional details are available on the ATROPEN profile page.

The generic ingredient in ATROPEN is atropine. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the atropine profile page.
Summary for 017106
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 017106
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106 NDA Meridian Medical Technologies LLC 11704-101 11704-101-01 .7 mL in 1 SYRINGE, PLASTIC (11704-101-01)
ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106 NDA Meridian Medical Technologies LLC 11704-104 11704-104-01 .7 mL in 1 SYRINGE, PLASTIC (11704-104-01)

Profile for product number 001

Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Approval Date:Jun 19, 2003TE:RLD:Yes

Profile for product number 003

Approval Date:Jun 19, 2003TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.